Sharp Rise In Device Adverse Reaction Cases Reported By Beijing Hospitals
This article was originally published in PharmAsia News
Executive Summary
Amid a campaign to enhance institutional monitoring of medical device adverse reactions in Class II health institutes, Beijing has received 393 reports of suspected AMDRs from 70 Class II healthcare institutes between May and Aug. 13.